Immune dysregulation in people with HIV, even those with higher CD4 counts, could potentiate a weaker immune response to Epstein–Barr virus-positive Burkitt lymphoma that remains asymptomatic for longer, leading to greater mortality risk and a more advanced stage at diagnosis [11]. This evidence concerns the gene CD4 and Burkitt lymphoma.